Archive for the Category ‘Health and Beauty’

Merck KGaA and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302

Merck KGaA and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302

DARMSTADT, Germany – Saturday, February 4th 2012 [ME NewsWire] Phase III soft tissue sarcoma trial ongoing; randomized Phase II pancreatic cancer trial expected to report in February 2012 Deal provides Threshold with an upfront payment of € 19 million ($25 million), plus further potential milestones and royalties as well as an option to co-commercialize in [...]

Health Discovery Corporation Launches Android Version of Popular MelApp, Melanoma Risk Analysis Mobile Phone App

Health Discovery Corporation Launches Android Version of Popular MelApp, Melanoma Risk Analysis Mobile Phone App

SAVANNAH, Ga. – Thursday, February 2nd 2012 [ME NewsWire] MelApp Named One of the Top Ten Apps that can Save Your Life in Parade Magazine (BUSINESS WIRE)– Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment, today debuts its popular MelApp [...]

FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes

FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes

INGELHEIM, Germany & INDIANAPOLIS – Wednesday, February 1st 2012 [ME NewsWire] New treatment combines DPP-4 inhibitor, linagliptin (the active ingredient in Trajenta™ [linagliptin] tablets), and metformin in a single tablet, taken twice-daily, to lower blood glucose in adults with Type 2 Diabetes (BUSINESS WIRE)–For Non-U.S. and Non-UK Media Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly [...]

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

Physicians request Solitaire™ FR device for randomized, open-label multi-center study MANSFIELD, Mass. – Monday, January 30th 2012 [ME NewsWire] (BUSINESS WIRE)– Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial. The Solitaire [...]

Healthy is the New Beautiful: Pantene Announces 11 Global Athletes as Its Newest Beauty Ambassadors

Healthy is the New Beautiful: Pantene Announces 11 Global Athletes as Its Newest Beauty Ambassadors

NEW YORK – Saturday, January 28th 2012 [ME NewsWire] (BUSINESS WIRE)– Pantene, the world’s leading haircare brand, today announced it will support 11 elite female athletes as its newest beauty ambassadors. The group will be featured in Pantene’s first global marketing campaign to support the Olympic Games. The athletes will provide proof that, regardless of [...]

Covidien Reports First-Quarter Results

Covidien Reports First-Quarter Results

DUBLIN – Sunday, January 29th 2012 [ME NewsWire] Net sales up 5%; Medical Devices sales up 6% First-quarter diluted GAAP earnings per share from continuing operations were $1.02; excluding specified items, adjusted diluted earnings per share from continuing operations were $1.13, up 19% Fiscal 2012 sales guidance updated (BUSINESS WIRE)– Covidien plc (NYSE: COV) today [...]

Roche Diagnostics to establish its Middle East regional headquarters in Jafza

Roche Diagnostics to establish its Middle East regional headquarters in Jafza

Diagnostics Company looks to expand current market share in MENA Region DUBAI, United Arab Emirates – Saturday, January 28th 2012 [ME NewsWire] Roche Diagnostics, diagnostic division of global healthcare company Roche announced that it will set up its Middle East headquarters in Jafza and commence operations next month. The announcement was made on the sidelines [...]

Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*

Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*

Two studies investigating afatinib* in patients with locally advanced or recurrent/metastatic head and neck cancer are open for recruitment. INGELHEIM, Germany – Thursday, January 26th 2012 [ME NewsWire] (BUSINESS WIRE)– FOR NON-US MEDIA ONLY Boehringer Ingelheim announced today the initiation of two phase III clinical trials, LUX-Head & Neck 1 and LUX-Head & Neck 2. [...]

BIOTRONIK Successfully Completes Testing of BIOTRONIK EHR DataSync®— Connecting BIOTRONIK Home Monitoring® to Electronic Health Record Systems

BIOTRONIK Successfully Completes Testing of BIOTRONIK EHR DataSync®— Connecting BIOTRONIK Home Monitoring® to Electronic Health Record Systems

LAKE OSWEGO, Ore. – Thursday, January 26th 2012 [ME NewsWire] (BUSINESS WIRE)– BIOTRONIK, a worldwide leader in manufacturing cardiac medical devices and pioneer of remote patient management solutions, today announced it has successfully completed its final interoperability testing process for BIOTRONIKHome Monitoring®, an Internet-based system for patient and implantable cardiac device information. IHE “Connectathon” During [...]

Oriflame Kicks off 45th Anniversary at Rio Conference

Oriflame Kicks off 45th Anniversary at Rio Conference

RIO DE JANEIRO – Wednesday, January 25th 2012 [ME NewsWire]   Top leaders gather to celebrate 45 years of fulfilling dreams (BUSINESS WIRE)– Oriflame (STO:ORISDB), the international beauty company selling direct, has announced the launch of its 45th anniversary celebrations at its Diamond Conference in Rio de Janeiro. Over 1,000 participants including Oriflame’s top Leaders [...]

Advertisement

Recently Commented